4.24
price up icon7.61%   0.30
after-market 시간 외 거래: 4.16 -0.08 -1.89%
loading
전일 마감가:
$3.94
열려 있는:
$4.24
하루 거래량:
1.17M
Relative Volume:
1.93
시가총액:
$130.09M
수익:
$875.70K
순이익/손실:
$-39.57M
주가수익비율:
-3.1588
EPS:
-1.3423
순현금흐름:
$-33.65M
1주 성능:
+8.72%
1개월 성능:
+16.16%
6개월 성능:
+78.53%
1년 성능:
+36.33%
1일 변동 폭
Value
$4.13
$4.6499
1주일 범위
Value
$3.69
$4.6499
52주 변동 폭
Value
$1.90
$4.6499

Vistagen Therapeutics Inc Stock (VTGN) Company Profile

Name
명칭
Vistagen Therapeutics Inc
Name
전화
650-577-3600
Name
주소
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Name
직원
57
Name
트위터
@vistagen
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
VTGN's Discussions on Twitter

VTGN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VTGN
Vistagen Therapeutics Inc
4.24 120.88M 875.70K -39.57M -33.65M -1.3423
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-12-07 업그레이드 Jefferies Hold → Buy
2023-08-07 업그레이드 Maxim Group Hold → Buy
2022-07-22 다운그레이드 Jefferies Buy → Hold
2022-07-22 다운그레이드 Robert W. Baird Outperform → Neutral
2022-07-22 다운그레이드 William Blair Outperform → Mkt Perform
2021-05-20 개시 Robert W. Baird Outperform
2021-02-18 개시 Jefferies Buy
2021-01-04 업그레이드 William Blair Mkt Perform → Outperform
2018-06-27 개시 Maxim Group Buy
2018-02-08 재확인 Chardan Capital Markets Buy
2017-03-28 개시 Maxim Group Buy
모두보기

Vistagen Therapeutics Inc 주식(VTGN)의 최신 뉴스

pulisher
01:07 AM

VistaGen stock rises after completing Phase 3 trial for anxiety drug - Investing.com

01:07 AM
pulisher
10:09 AM

Is Vistagen Therapeutics Inc. a candidate for recovery play2025 Earnings Surprises & Low Drawdown Investment Strategies - newser.com

10:09 AM
pulisher
09:10 AM

How Vistagen Therapeutics Inc. stock compares to industry benchmarksWeekly Market Outlook & Low Volatility Stock Suggestions - newser.com

09:10 AM
pulisher
08:33 AM

Will Vistagen Therapeutics Inc. stock remain a Wall Street favoriteGap Down & Precise Buy Zone Tips - newser.com

08:33 AM
pulisher
08:30 AM

Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder - Yahoo Finance

08:30 AM
pulisher
06:36 AM

Vistagen Therapeutics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView

06:36 AM
pulisher
06:07 AM

Can Vistagen Therapeutics Inc. stock deliver surprise earnings beatPortfolio Risk Summary & Fast Gaining Stock Strategy Reports - newser.com

06:07 AM
pulisher
04:07 AM

Strategies to average down on Vistagen Therapeutics Inc.Risk Management & Safe Entry Zone Identification - newser.com

04:07 AM
pulisher
02:55 AM

What dividend safety score for Vistagen Therapeutics Inc. stockQuarterly Trade Report & Low Volatility Stock Recommendations - newser.com

02:55 AM
pulisher
02:19 AM

Is Vistagen Therapeutics Inc. stock reversal real or fake2025 Retail Activity & Real-Time Volume Triggers - newser.com

02:19 AM
pulisher
01:32 AM

Will breakout in Vistagen Therapeutics Inc. lead to full recoveryEarnings Miss & High Return Trade Opportunity Guides - newser.com

01:32 AM
pulisher
12:06 PM

Will Vistagen Therapeutics Inc. stock benefit from green energy trends2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com

12:06 PM
pulisher
Nov 02, 2025

Is Vistagen Therapeutics Inc. stock a safe haven assetWeekly Stock Recap & High Accuracy Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Vistagen Therapeutics Inc. stock gain from strong economy2025 Top Decliners & Fast Gain Swing Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Should you hold or exit Vistagen Therapeutics Inc. nowWeekly Risk Summary & Weekly Watchlist for Hot Stocks - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Vistagen Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Reactions & Intraday High Probability Setup Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Technical signs of recovery in Vistagen Therapeutics Inc.CPI Data & Community Consensus Stock Picks - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Visualizing Vistagen Therapeutics Inc. stock with heatmapsOptions Play & Technical Pattern Alert System - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 04:45:37 - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Combining machine learning predictions for Vistagen Therapeutics Inc.CEO Change & Reliable Price Action Trade Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How to recover losses in Vistagen Therapeutics Inc. stockJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How to escape a deep drawdown in Vistagen Therapeutics Inc.Day Trade & Low Risk Investment Opportunities - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

VistaGen Therapeutics Appoints Paul R. Edick to Board - The Globe and Mail

Oct 30, 2025
pulisher
Oct 30, 2025

Vistagen’s Promising Phase 2 Trial for Anxiety Treatment: A Market Game Changer? - MSN

Oct 30, 2025

Vistagen Therapeutics Inc (VTGN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
자본화:     |  볼륨(24시간):